T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Amazon
AMZN
|
+$3.55B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.02B |
| 3 |
EQT Corp
EQT
|
+$1.52B |
| 4 |
Adobe
ADBE
|
+$1.29B |
| 5 |
Constellation Energy
CEG
|
+$1.16B |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.09B |
| 2 |
UnitedHealth
UNH
|
+$1.75B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.69B |
| 4 |
Ross Stores
ROST
|
+$1.64B |
| 5 |
ASML
ASML
|
+$1.59B |
Sector Composition
| 1 | Technology | 31.66% |
| 2 | Healthcare | 16.93% |
| 3 | Consumer Discretionary | 11.06% |
| 4 | Financials | 10.59% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Innoviva
INVA
$1.22B
| $606K | ﹤0.01% |
47,541
+1,243
| +3% | +$15.8K |
|
2027
Wolverine World Wide
WWW
$2.48B
| $605K | ﹤0.01% |
41,173
+802
| +2% | +$11.8K |
|
2028
Vicor
VICR
$2.28B
| $602K | ﹤0.01% |
11,143
+204
| +2% | +$11K |
|
2029
Flushing Financial
FFIC
$476M
| $597K | ﹤0.01% |
48,543
+180
| +0.4% | +$2.21K |
|
2030
MRC Global
MRC
$1.23B
| $597K | ﹤0.01% |
59,203
+1,421
| +2% | +$14.3K |
|
2031
Oxford Industries
OXM
$701M
| $595K | ﹤0.01% |
6,037
+160
| +3% | +$15.8K |
|
2032
MannKind Corp
MNKD
$1.71B
| $590K | ﹤0.01% |
144,871
+10,735
| +8% | +$43.7K |
|
2033
Beazer Homes USA
BZH
$781M
| $588K | ﹤0.01% |
20,773
+386
| +2% | +$10.9K |
|
|
BBT
2034
Beacon Financial Corporation
BBT
$2.17B
| $587K | ﹤0.01% |
28,282
+709
| +3% | +$14.7K |
|
2035
Eagle Bancorp
EGBN
$615M
| $584K | ﹤0.01% |
27,563
+2,320
| +9% | +$49.2K |
|
2036
Veeco
VECO
$1.52B
| $584K | ﹤0.01% |
22,738
+737
| +3% | +$18.9K |
|
2037
Zeta Global
ZETA
$4.84B
| $583K | ﹤0.01% |
68,190
+23,438
| +52% | +$200K |
|
2038
Brookdale Senior Living
BKD
$1.78B
| $582K | ﹤0.01% |
137,848
-39,253
| -22% | -$166K |
|
|
ADAM
2039
Adamas Trust, Inc. Common Stock
ADAM
$654M
| $582K | ﹤0.01% |
58,578
+1,363
| +2% | +$13.5K |
|
2040
Univest Financial
UVSP
$886M
| $582K | ﹤0.01% |
32,150
+4,063
| +14% | +$73.6K |
|
2041
Acco Brands
ACCO
$361M
| $581K | ﹤0.01% |
111,501
+1,756
| +2% | +$9.15K |
|
2042
Collegium Pharmaceutical
COLL
$1.18B
| $580K | ﹤0.01% |
26,970
+422
| +2% | +$9.08K |
|
|
MCBC
2043
DELISTED
Macatawa Bank Corp
MCBC
| $580K | ﹤0.01% |
62,396
+4,325
| +7% | +$40.2K |
|
2044
The Greenbrier Companies
GBX
$1.42B
| $576K | ﹤0.01% |
13,350
+362
| +3% | +$15.6K |
|
|
BRSP
2045
BrightSpire Capital
BRSP
$764M
| $575K | ﹤0.01% |
85,413
+14,278
| +20% | +$96.1K |
|
2046
Caleres
CAL
$503M
| $574K | ﹤0.01% |
23,947
+412
| +2% | +$9.88K |
|
2047
Recursion Pharmaceuticals
RXRX
$2.11B
| $574K | ﹤0.01% |
76,826
+2,033
| +3% | +$15.2K |
|
2048
Coursera
COUR
$1.8B
| $573K | ﹤0.01% |
43,976
-11,541
| -21% | -$150K |
|
2049
Virgin Galactic
SPCE
$191M
| $573K | ﹤0.01% |
7,379
+748
| +11% | +$58.1K |
|
2050
Travere Therapeutics
TVTX
$2.09B
| $571K | ﹤0.01% |
37,151
+5,861
| +19% | +$90.1K |
|